Vaccines can win the race against COVID-19 variants. Here's how
COVID-19 variants threaten to undermine global vaccine programmes unless we accelerate the pace of delivery and rise to the challenge of global deployment.
COVID-19 variants threaten to undermine global vaccine programmes unless we accelerate the pace of delivery and rise to the challenge of global deployment.
The COVID-19 pandemic has stalled the number of people being diagnosed with TB. In response, these public-private initiatives are working to reach them.
Johnson & Johnson has announced a 10-year initiative to combat TB, with a triple-track approach focused on expanding access to current therapies, increasing diagnosis rates and invest...
More financing, new public private partnerships to tackle brain science and a different dialogue around brain health are critical to tackling mental illness on a global scale.